Neurometrix Inc Asset Turnover Ratio (NURO), as of fourth quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Neurometrix Inc   (NASDAQ: NURO)
 

Neurometrix Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Neurometrix Inc asset turnover ratio, the ability of Neurometrix Inc 's assets to generate revenue in the fourth quarter 2024, increased sequentially to 0.15 in the fourth quarter (Dec 31 2024), yet the ratio remained below the average, as NURO's position remain challenging.

Within sector 36 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the IV Quarter 2024, to 1290, from total ranking in the third quarter 2024 at 1540.

Asset Turnover Ratio Definition



NURO Asset Turnover Ratio (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Asset Change -28.47 % -19.25 % -16.88 % -12.48 % -13.15 %
Y / Y Revenue Change -36.86 % -51.19 % -53.55 % -36.6 % -80.31 %
Asset Turnover Ratio (TTM) 0.15 0.14 0.17 0.2 0.22
NURO's Total Ranking # 1290 # 1540 # 1118 # 1401 # 1157
Seq. Asset Change -10.85 % -9.2 % -8.39 % -3.55 % 0.65 %
Seq. Revenue Change -60.9 % -23.64 % -29.67 % 200.65 % -69.77 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 37
Healthcare Sector # 121
Overall Market # 1290

Asset Turnover Ratio Statistics
High Average Low
22.77 13.34 7.28
(Mar 31 2017)   (Jun 30 2024)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2024 Assets at quarter ending Dec 31 2024
Ss Innovations International Inc  0.47 $ 17.567  Millions$ 37.031  Millions
Edwards Lifesciences Corporation  0.47 $ 5,439.000  Millions$ 11,465.525  Millions
Amphastar Pharmaceuticals Inc   0.47 $ 733.805  Millions$ 1,547.122  Millions
Stevanato Group S p a   0.47 $ 1,236.520  Millions$ 2,608.277  Millions
Genfit S a   0.47 $ 79.452  Millions$ 169.595  Millions
Guardant Health Inc   0.47 $ 739.016  Millions$ 1,584.569  Millions
Vireo Growth Inc.  0.46 $ 99.384  Millions$ 214.574  Millions
Pulmatrix Inc   0.46 $ 7.806  Millions$ 16.906  Millions
Collegium Pharmaceutical Inc   0.46 $ 630.005  Millions$ 1,366.596  Millions
Arcutis Biotherapeutics Inc   0.46 $ 196.542  Millions$ 427.386  Millions
Ontrak Inc   0.45 $ 10.824  Millions$ 23.868  Millions
Skinhealth Systems Inc   0.45 $ 333.296  Millions$ 735.451  Millions
Semler Scientific inc   0.45 $ 56.294  Millions$ 125.166  Millions
Marker Therapeutics inc   0.45 $ 6.591  Millions$ 14.675  Millions
Avanos Medical Inc   0.45 $ 686.900  Millions$ 1,532.375  Millions
Orthopediatrics Corp  0.45 $ 204.598  Millions$ 457.612  Millions
Coherus Oncology inc   0.45 $ 266.960  Millions$ 597.983  Millions
Redhill Biopharma Ltd   0.45 $ 8.043  Millions$ 18.043  Millions
Assertio Holdings inc   0.45 $ 124.961  Millions$ 280.535  Millions
Ptc Therapeutics inc   0.44 $ 806.780  Millions$ 1,813.311  Millions
Pacira Biosciences inc   0.44 $ 700.966  Millions$ 1,576.337  Millions
Boston Scientific Corporation  0.44 $ 16,747.000  Millions$ 37,812.500  Millions
Blueprint Medicines Corporation  0.44 $ 508.824  Millions$ 1,155.374  Millions
Bio techne Corp  0.44 $ 1,195.430  Millions$ 2,716.230  Millions
Cvrx inc   0.44 $ 50.958  Millions$ 115.810  Millions
Aurinia Pharmaceuticals Inc   0.44 $ 235.133  Millions$ 535.042  Millions
Envista Holdings Corporation  0.44 $ 2,509.700  Millions$ 5,713.900  Millions
Brainsway Ltd   0.43 $ 41.016  Millions$ 94.316  Millions
Exact Sciences Corporation  0.43 $ 2,788.463  Millions$ 6,431.581  Millions
Kamada Ltd   0.43 $ 160.953  Millions$ 372.255  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.